Llwytho...
Current Progress in CAR-T Cell Therapy for Hematological Malignancies
Immunotherapies, such as monoclonal antibody therapy and checkpoint inhibitor therapy, have shown inspiring clinical effects for the treatment of cancer. Chimeric antigen receptor T (CAR-T) cells therapy was an efficacious therapeutic approach treating hematological malignancies and encouraging resu...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Cancer |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Ivyspring International Publisher
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7738987/ https://ncbi.nlm.nih.gov/pubmed/33391429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.48976 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|